RGEBX
Price
$81.40
Change
-$0.06 (-0.07%)
Updated
Aug 15 closing price
Net Assets
329.22B
STCAX
Price
$17.33
Change
-$0.04 (-0.23%)
Updated
Aug 15 closing price
Net Assets
249.41M
Interact to see
Advertisement

RGEBX vs STCAX

Header iconRGEBX vs STCAX Comparison
Open Charts RGEBX vs STCAXBanner chart's image
American Funds Growth Fund of Amer R2E
Price$81.40
Change-$0.06 (-0.07%)
VolumeN/A
Net Assets329.22B
Virtus Silvant Large-Cap Growth Stk I
Price$17.33
Change-$0.04 (-0.23%)
VolumeN/A
Net Assets249.41M
RGEBX vs STCAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RGEBX vs. STCAX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGEBX is a Buy and STCAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 329B vs. STCAX (249M). RGEBX (0.00) and STCAX (0.00) have matching dividends . RGEBX was incepted earlier than STCAX: RGEBX (11 years) vs STCAX (33 years). RGEBX (1.09) and STCAX (1.06) have similar cost to investors . RGEBX is a more actively managed with annual turnover of: 25.00 vs. STCAX (12.00). RGEBX has a lower initial minimum investment than STCAX: RGEBX (250) vs STCAX (100000). STCAX annual gain was more profitable for investors over the last year : 20.51 vs. RGEBX (13.85). STCAX return over 5 years is better than : 80.52 vs. RGEBX (40.64).
RGEBXSTCAXRGEBX / STCAX
Total Expense Ratio1.090.77142%
Annual Report Gross Expense Ratio1.091.06103%
Fund Existence11 years33 years-
Gain YTD13.94211.951117%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets329B249M132,129%
Annual Yield % from dividends0.000.00-
Returns for 1 year13.8520.5167%
Returns for 3 years40.3876.8453%
Returns for 5 years40.6480.5250%
Returns for 10 years79.5060.61131%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYCFX43.780.47
+1.09%
Rydex Biotechnology C
FKALX52.150.07
+0.13%
Federated Hermes Kaufmann Small Cap R6
MSGCX10.910.01
+0.09%
Meridian Small Cap Growth C
BIAFX43.78-0.01
-0.02%
Brown Advisory Flexible Equity Inv
JUEZX26.64-0.10
-0.37%
JPMorgan US Equity R2